2021-01-06,Provention Bio to Participate in the H.C. Wainwright Virtual BioConnect Conference
2021-01-04,Provention Bio Announces U.S. FDA Filing of a Biologics License Application (BLA) and Priority Review for Teplizumab for the Delay or Prevention of Clinical Type 1 Diabetes in At-risk Individuals
2020-12-21,Provention Bio Announces Addition to NASDAQ Biotechnology Index
2020-12-21,Companies Like Provention Bio (NASDAQ:PRVB) Are In A Position To Invest In Growth
2020-12-15,Provention Bio Initiates First-in-Human Study of Coxsackievirus B Vaccine Candidate PRV-101
2020-12-10,Is PRVB A Good Stock To Buy Now?
2020-12-08,JDRF Launches First Mass Screening Program for Early-Stage Type 1 Diabetes (T1D) Detection
2020-12-04,New Strong Sell Stocks for December 4th
2020-11-25,New Strong Sell Stocks for November 25th
2020-11-11,Provention Bio to Present at the Stifel Virtual Healthcare Conference
2020-11-10,Oppenheimer Sees These 3 Stocks Skyrocketing Over 100%
2020-11-06,"Provention Bio, Inc (PRVB) Q3 2020 Earnings Call Transcript"
2020-11-05,Provention Bio Reports Third Quarter 2020 Financial Results and Provides Business Update
2020-11-05,"Provention Bio, Inc. to Host Earnings Call"
2020-11-02,Provention Bio Completes Rolling Submission of the Biologics License Application (BLA) for Teplizumab for the Delay or Prevention of Clinical Type 1 Diabetes in At-risk Individuals
2020-10-29,"Provention Bio to Report Third Quarter 2020 Financial Results and Host Conference Call on Thursday, November 5, 2020"
2020-10-20,"Have Insiders Been Buying Provention Bio, Inc. (NASDAQ:PRVB) Shares?"
2020-10-01,Provention Bio Announces National Effort to Redefine Patient Care in Type 1 Diabetes (T1D)
2020-09-30,Provention Bio Files Clinical Module for Teplizumab for the Delay or Prevention of Clinical Type 1 Diabetes in At-Risk Individuals
2020-09-08,Is the Options Market Predicting a Spike in Provention Bio (PRVB) Stock?
2020-09-08,Provention Bio to Present at Upcoming Virtual Investor Conferences
2020-08-31,Provention Bio Announces Initiation of Phase 2b PROACTIVE Study of PRV-015 (anti-IL-15) in Non-responsive Celiac Disease
2020-08-25,"AGC Biologics Completes PPQ Manufacturing Campaign with Provention Bio for Type 1 Diabetes Product Candidate, Teplizumab"
2020-08-19,"Is Provention Bio, Inc. (NASDAQ:PRVB) Popular Amongst Insiders?"
2020-08-13,2 Revolutionary Biotech Stocks to Buy Right Now
2020-08-11,"John K. Jenkins, MD Joins Provention Bio Board of Directors"
2020-08-06,Provention Bio Reports Second Quarter 2020 Financial Results and Provides Business Update
2020-08-03,Provention Bio Appoints Heidy Abreu King-Jones as Chief Legal Officer
2020-07-30,"Provention Bio to Report Second Quarter 2020 Financial Results and Host Conference Call on Thursday, August 6, 2020"
2020-07-02,Why This Under-the-Radar Biotech Stock Could Skyrocket
2020-06-30,Provention Bio Announces Change to a Virtual Meeting Format for the 2020 Annual Meeting of the Stockholders
2020-06-29,Provention Bio Announces Inclusion in the Russell 3000 Index and Russell 2000 Index
2020-06-22,Provention Bio Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
2020-06-22,"Hedge Funds Are Selling Provention Bio, Inc. (PRVB)"
2020-06-19,Provention Bio (NASDAQ:PRVB) Is In A Good Position To Deliver On Growth Plans
2020-06-17,Provention Bio Announces Pricing of $95.7 Million Public Offering of Common Stock
2020-06-16,Provention Bio Announces Proposed Public Offering of Common Stock
2020-06-16,Provention Bio (PRVB) Looks Good: Stock Adds 8.6% in Session
2020-06-15,Why Provention Bio Jumped Today
2020-06-15,Provention Bio's Teplizumab Continued to Significantly Delay the Onset of Insulin-Dependent Type 1 Diabetes (T1D) in Presymptomatic Patients
2020-05-28,Provention Bio to Present at the Jefferies Virtual Healthcare Conference
2020-05-20,Provention Bio Announces Changes to its Board of Directors
2020-05-18,Provention Bio and Vactech Announce Publication of Proof-of-Concept Data for a Preclinical Prototype of Coxsackievirus B Vaccine
2020-05-08,"Provention Bio, Inc (PRVB) Q1 2020 Earnings Call Transcript"
2020-04-30,"Provention Bio to Report First Quarter 2020 Financial Results and Host Conference Call on Thursday, May 7, 2020"
2020-04-16,Provention Bio Initiates Rolling Submission of Biologic License Application for Teplizumab for the Delay or Prevention of Clinical Type 1 Diabetes in At-Risk Individuals
2020-04-01,Provention Bio (PRVB) Soars: Stock Adds 6.4% in Session
2020-03-21,"Insider Buying: The Provention Bio, Inc. (NASDAQ:PRVB) Co-Founder & Chief Scientific Officer Just Bought US$59k Worth Of Shares"
2020-03-17,"The Daily Biotech Pulse: Setback For DBV In Peanut Allergy Patch Review, Roche Starts Coronavirus Test Shipment, Regeneron Aims For 'Cocktail' COVID-19 Treatment"
2020-03-16,Provention Bio Provides Update on the Status of Its Phase 3 PROTECT Study for the Treatment of Newly Diagnosed Type 1 Diabetes
2020-03-12,Provention Bio Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update
2020-03-12,Provention Announces Positive Data from Phase 1b PREVAIL Study of PRV-3279
2020-03-05,"Provention Bio to Report Fourth Quarter and Full Year 2019 Financial Results and Host Conference Call on Thursday, March 12, 2020"
2020-02-19,Provention Bio to Present at Upcoming Conferences
2020-02-05,"Should You Take Comfort From Insider Transactions At Provention Bio, Inc. (NASDAQ:PRVB)?"
2020-01-23,Johnson & Johnson Sold a Hot Biotech Stock
2020-01-08,Provention Bio Appoints Jason Hoitt as Chief Commercial Officer
2019-12-30,Weekly CEO Buys Highlight
2019-12-17,"Hedge Funds Have Never Been This Bullish On Provention Bio, Inc. (PRVB)"
2019-12-12,Provention Bio Reiterates Regulatory Guidance for PRV-031 (Teplizumab) Following Meeting with the FDA
2019-12-05,Boston investment firm led by former Bain Capital exec fuels diabetes research
2019-12-04,"Here's Why Momentum Investors Will Love Provention Bio, Inc. (PRVB)"
2019-11-21,Will Provention Bio Continue to Surge Higher?
2019-11-05,Provention Bio Reports Third Quarter 2019 Financial Results
2019-10-29,Will Provention Bio (NASDAQ:PRVB) Spend Its Cash Wisely?
2019-10-29,"Provention Bio to Report Third Quarter 2019 Financial Results and Host Conference Call on Tuesday, November 5, 2019"
2019-10-24,Provention Bio Announces PRV-031 (Teplizumab) Granted PRIME Designation by the European Medicines Agency
2019-10-22,"Provention Bio Reports Top Line Results from Phase 2a PRINCE Clinical Trial with PRV-6527, an Oral CSF-1R Inhibitor, in Patients with Moderate to Severe Crohn's Disease"
2019-09-26,Sean Doherty Joins Provention Bio Board of Directors
2019-09-25,Provention Bio to Present at the 2019 Cantor Global Healthcare Conference
2019-09-24,Provention Bio Reiterates Regulatory Strategy for PRV-031 and Announces Completion of Follow-on Financing
2019-09-19,"The Daily Biotech Pulse: China Biologics Receives Buyout Offer, Provention Bio Offering, Exagen IPO"
2019-09-18,Provention Bio Announces Pricing of $40 Million Public Offering of Common Stock
2019-09-18,Provention Bio Announces Proposed Public Offering of Common Stock
2019-08-27,"Need To Know: Provention Bio, Inc. (NASDAQ:PRVB) Insiders Have Been Buying Shares"
2019-08-20,Provention Bio Announces Key Addition to its Leadership Team
2019-08-09,"Provention Bio Inc (PRVB) President and CEO Ashleigh Palmer Bought $96,990 of Shares"
2019-08-08,Provention Bio Initiates Phase 1b/2a PREVAIL Clinical Trial Evaluating PRV-3279 in Lupus
2019-08-06,Provention Bio Reports Second Quarter 2019 Financial Results
2019-08-05,"A Look At Benzinga Pro's Most-Searched Tickers For August 5, 2019"
2019-08-05,Provention Bio Announces Breakthrough Therapy Designation for Teplizumab (PRV-031) for the Prevention or Delay of Clinical Type 1 Diabetes in At-Risk Individuals
2019-07-12,5 Best Biotech Stocks of 2019 So Far
2019-07-01,ActoBio Therapeutics Progresses AG019 to Next Stage of a Phase Ib/IIa Clinical Study for the Treatment of Type 1 Diabetes
2019-06-14,Why Consistent Trading Doesn't Always Lead To Consistent Results
2019-06-13,"Provention Bio Cancels Secondary Offering, Shares Rally"
2019-06-13,Provention Bio's stock surges after calling off public stock offering
2019-06-13,Provention Bio Announces Termination of Public Offering of Common Stock
2019-06-12,2 Small Biotechs With Sagging Shares but Promising Prospects
2019-06-11,"Company News For Jun 11, 2019"
2019-06-11,"The Daily Biotech Pulse: Lilly Reports Positive Long-Term Efficacy Data For Psoriasis Drug, Provention Bio Offering"
2019-06-10,Provention Bio Announces Proposed Public Offering of Common Stock
2019-06-10,Provention Bio News: Why PRVB Stock Is Skyrocketing Today
2019-06-09,A Single Course of Provention's PRV-031 (Teplizumab) Delays Type 1 Diabetes Onset in High-Risk Individuals by at Least Two Years
2019-05-27,"Could The Provention Bio, Inc. (NASDAQ:PRVB) Ownership Structure Tell Us Something Useful?"
2019-05-09,"The Daily Biotech Pulse: Novartis Goes Shopping, Mixed Trial Results For Provention Bio, 4 Stocks To Debut"
2019-05-08,Provention Bio Reports First Quarter 2019 Financial Results
2019-05-08,Provention Bio Announces Top-Line Results from its Phase 1b PULSE Clinical Trial of PRV-300 in Patients with Moderate-to-Severe Ulcerative Colitis
2019-04-24,Provention Bio Completes Enrollment of Phase 2a PRINCE Clinical Trial with PRV-6527 in Patients with Moderate to Severe Crohn's Disease
2019-04-12,"Provention Bio, Inc. (PRVB) Shares March Higher, Can It Continue?"
2019-04-09,Provention Bio Initiates Phase 3 PROTECT Clinical Trial with PRV-031 (Teplizumab) in Patients with Recent Onset Type 1 Diabetes
